Company Description
ABOUT LGC:
LGC is a leading, global life science tools company, providing mission-critical components and solutions into high-growth application areas across the human healthcare and applied market segments. Its high-quality product portfolio is comprised of mission-critical tools for genomic analysis and for quality assurance applications, which are typically embedded and recurring within our customers’ products and workflows and are valued for their performance, quality, and range.
Job Description
Reporting directly to the Group Finance Director (Commercial) with a secondary reporting line to the relevant Business Unit Finance Director, this new role will be accountable for coordinating the timely delivery of all finance inputs required from the relevant Business Unit in support of LGC’s shareholder exit readiness programme.
The finance inputs for the programme and associated timing will be determined by Group Finance, in consultation with Business Unit Finance Directors. This role will then work to deliver these items either directly or through members of the relevant Business Unit Finance team and/or Analytics business partners. Final signoff/approval will remain the responsibility of the Business Unit Finance Director.
In order to deliver the required financial inputs, the role will interact with a wide range of senior stakeholders and will be required to develop a close working relationship with Group and Business Unit Finance teams; Business Unit Senior Leadership teams (‘SLT’); managers in other LGC functions as well as external advisors (principally financial and commercial due diligence providers).
The right candidate will be able to add value, through their understanding of the financial data requirements for an exit process and an ability to quickly understand a complex business, by ensuring (through appropriate support and challenge) that requested inputs from the Business Unit meet the requirements of a detailed due diligence process.
Examples of finance inputs into the exit readiness programme, are as follows:
- A detailed 5 Year forecast strategic and operating model and supporting data points/analysis (linked to the Business Unit’s historical financial track record)
- Explanations of key performance trends across all financial statements over the historical track record at aggregate; functional and operating site levels
- Supporting relevant Group and /or Business Unit SLT members in the development and articulation of strategies in areas of future value creation such as e-commerce; APAC region growth; new product development; and site footprint
- Aggregation, review and explanation of historical and forecast headcount by function and associated cost
- Aggregation and presentation of data/evidence (incl relevant KPIs) of the delivery of efficiency and productivity benefits across the relevant Business Unit’s operations and supply chain incl procurement benefits and returns from capital investments
- Collation and analysis of data required to support Commercial Due Diligence in the relevant Business Unit, including product and customer segmentation versus relevant market data, price volume analysis, new customer acquisition and churn; and competitor analysis
- Collation and review of the M&A track record of the relevant Business Unit, including evidence of synergy delivery
During a shareholder change project, in addition to the completion of due diligence requirements, the role will be expected to play a significant part in the provision of responses to Q&A from potential investors (working within an agreed quality control/review framework).
Qualifications
The ideal applicant will be a high calibre, experienced M&A practitioner who thrives working in a hands-on, fast paced, dynamic working environment. You will be confident with financial due diligence requirements; data analytics; business planning & modelling; have good attention to detail, enjoy finding pragmatic solutions to complex solutions; and demonstrate strong reporting and communication skills.
You will be expected to lead assigned work to a successful conclusion, with an ability to work independently albeit whilst keeping relevant stakeholders appraised of progress. Specific role requirements are:
- Degree: 1st or 2.1
- M&A transaction experience, including supporting due diligence and integration activities
- Qualified accountant
- Strong reporting and analytical skills
- Strong project management skills
- Confident in advanced MS Excel techniques and modelling
- Personable, with a strong commitment to team outcomes
- Ability to quickly build strong working relationships with senior business stakeholders
- Excellent written communication and presentation skills
- Quick to get up to speed, able to evidence strong problem solving skills
Additional Information
OUR VALUES
- PASSION
- CURIOSITY
- INTEGRITY
- BRILLIANCE
- RESPECT
EQUAL OPPORTUNITIES
LGC strongly believes that every job applicant and employee should be valued for their individual talents regardless of age, disability, race, color, ethnic or national origin, sex, sexual orientation, gender reassignment, marital or civil partnership, pregnancy or maternity, religion, or belief. Short listing, interviewing and selection will always be carried out without regard to gender, sexual orientation, marital status, color, race, nationality, ethnic or national origins, religion or belief, age, or trade union membership.
For more information about LGC, please visit our website www.lgcgroup.com
#scienceforasaferworld
What We Do
LGC is a leading, global life science tools company, providing mission-critical components and solutions into high-growth application areas across the human healthcare and applied market segments. Its high quality product portfolio is comprised of mission-critical tools for genomic analysis and for quality assurance applications, which are typically embedded and recurring within our customers’ products and workflows and are valued for their performance, quality and range.
LGC’s tools play a key role in customer workflows from discovery applications through to commercial manufacture and enable its customers to: bring new diagnostics and therapies to market; progress research and development; optimise food production; and continuously monitor and enhance the quality of food, the environment and consumer products.
LGC’s 175+ years of scientific heritage, combined with a track record of innovation and value-enhancing acquisitions, has enabled the company to build its product portfolio and expertise, and develop deep relationships with customers, industry partners and the global scientific community.
LGC’s core purpose of Science for a safer world and its core values of passion, curiosity, integrity, brilliance and respect, drive its culture. As of 30 June 2021, it employs 4,350 employees, of which over 1,175 employees hold PhD and/or master’s degrees. Its products and services are delivered by highly qualified and experienced teams, operating from a global network of accredited sites that showcase its scientific and manufacturing capabilities.
